Bendibel, Rhian Jay D.

HRN: 25-92-77  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/18/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/18/2025
04/25/2025
IV
280 Mg
Q 6 Hours
UTI
Waiting Final Action 
04/19/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
04/19/2025
04/29/2025
PO
3ml
Q 8 Hours
Amoebiasis
Waiting Final Action 
04/22/2025
CEFUROXIME 750MG (VIAL)
04/22/2025
04/29/2025
IV
230mg
Q8H
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: